开云app官网登录入口网页版-官方正版

#脂肪性#

235篇内容 | 3130人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1810236, encodeId=03af181023666, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Hepatology | 非酒精性脂肪性肝炎的潜在治疗新靶点被发现, objectType=article, longId=733353, objectId=f035e33353ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f035e33353ca, replyNumber=0, likeNumber=106, createdTime=2023-03-19, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f035e33353ca, moduleTitle=Hepatology | 非酒精性脂肪性肝炎的潜在治疗新靶点被发现, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f035e33353ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810239, encodeId=4cfa1810239f1, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=European Radiology：在接受NAC的乳腺癌患者中，测量这一影像学指标可预测化疗相关脂肪性肝炎！, objectType=article, longId=735944, objectId=edb5e359444e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edb5e359444e, replyNumber=0, likeNumber=91, createdTime=2022-08-21, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edb5e359444e, moduleTitle=European Radiology：在接受NAC的乳腺癌患者中，测量这一影像学指标可预测化疗相关脂肪性肝炎！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=edb5e359444e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810240, encodeId=4013181024035, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Radiology：超声衰减成像在非酒精性脂肪性肝炎诊断中的应用, objectType=article, longId=739482, objectId=7a25e394825a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a25e394825a, replyNumber=0, likeNumber=0, createdTime=2023-06-08, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a25e394825a, moduleTitle=Radiology：超声衰减成像在非酒精性脂肪性肝炎诊断中的应用, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=7a25e394825a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810235, encodeId=38a7181023575, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=FDA授予辉瑞Ervogastat/Clesacostat用于非酒精性脂肪性肝炎 (NASH) 的快速通道资格, objectType=article, longId=728015, objectId=c099e2801596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c099e2801596, replyNumber=0, likeNumber=125, createdTime=2022-11-01, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c099e2801596, moduleTitle=FDA授予辉瑞Ervogastat/Clesacostat用于非酒精性脂肪性肝炎 (NASH) 的快速通道资格, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c099e2801596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810237, encodeId=10d4181023e0c, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Neurology：非酒精性脂肪性肝病和纤维化与偶发痴呆和认知的相关性:鹿特丹研究, objectType=article, longId=733617, objectId=85f4e3361710, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85f4e3361710, replyNumber=0, likeNumber=101, createdTime=2023-03-26, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85f4e3361710, moduleTitle=Neurology：非酒精性脂肪性肝病和纤维化与偶发痴呆和认知的相关性:鹿特丹研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=85f4e3361710)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810234, encodeId=af7718102344e, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=非酒精性脂肪性肝炎的免疫细胞介导特征, objectType=article, longId=727254, objectId=0c1be272546c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c1be272546c, replyNumber=0, likeNumber=107, createdTime=2023-03-21, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c1be272546c, moduleTitle=非酒精性脂肪性肝炎的免疫细胞介导特征, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=0c1be272546c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810238, encodeId=2eca1810238a9, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Neurology：非酒精性脂肪性肝病:这种代谢状况有脑功能后遗症吗？, objectType=article, longId=733621, objectId=c7b3e336210e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7b3e336210e, replyNumber=0, likeNumber=77, createdTime=2022-08-19, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7b3e336210e, moduleTitle=Neurology：非酒精性脂肪性肝病:这种代谢状况有脑功能后遗症吗？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c7b3e336210e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810227, encodeId=1e34181022efb, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=APT：胰高糖素样肽-1受体激动剂在非酒精性脂肪性肝炎、肥胖和糖尿病中的作用！, objectType=article, longId=300963, objectId=0b32300963be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b32300963be, replyNumber=0, likeNumber=103, createdTime=2022-10-29, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b32300963be, moduleTitle=APT：胰高糖素样肽-1受体激动剂在非酒精性脂肪性肝炎、肥胖和糖尿病中的作用！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=0b32300963be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810229, encodeId=2b9318102291c, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=APT：胰高糖素样肽-1受体激动剂在非酒精性脂肪性肝炎、肥胖和糖尿病中的作用, objectType=article, longId=301055, objectId=3c31301055f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c31301055f6, replyNumber=0, likeNumber=74, createdTime=2022-04-27, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c31301055f6, moduleTitle=APT：胰高糖素样肽-1受体激动剂在非酒精性脂肪性肝炎、肥胖和糖尿病中的作用, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3c31301055f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810223, encodeId=d30a18102236a, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Eur Heart J：复方丸预防心血管疾病，重点是非酒精性脂肪性肝炎, objectType=article, longId=294480, objectId=a62a294480a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a62a294480a6, replyNumber=0, likeNumber=86, createdTime=2022-05-26, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a62a294480a6, moduleTitle=Eur Heart J：复方丸预防心血管疾病，重点是非酒精性脂肪性肝炎, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a62a294480a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810225, encodeId=0d57181022529, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=JAMA Netw Open：成人2型糖尿病合并非酒精性脂肪性肝病严重低血糖分析, objectType=article, longId=300092, objectId=6b8530009223, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b8530009223, replyNumber=0, likeNumber=97, createdTime=2022-08-04, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b8530009223, moduleTitle=JAMA Netw Open：成人2型糖尿病合并非酒精性脂肪性肝病严重低血糖分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=6b8530009223)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810228, encodeId=4d69181022816, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Front Immunol：银屑病与非酒精性脂肪性肝病之间的双向关联, objectType=article, longId=301030, objectId=b94f30103017, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b94f30103017, replyNumber=0, likeNumber=106, createdTime=2023-03-02, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b94f30103017, moduleTitle=Front Immunol：银屑病与非酒精性脂肪性肝病之间的双向关联, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b94f30103017)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810220, encodeId=0f3c1810220ea, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=J Hepatol：口服FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的疗效, objectType=article, longId=220041, objectId=456022004188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=456022004188, replyNumber=0, likeNumber=73, createdTime=2021-11-23, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=456022004188, moduleTitle=J Hepatol：口服FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的疗效, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=456022004188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810231, encodeId=b5ef181023150, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Biomed Pharmacother：中药复方菩人丹可减轻老年2型糖尿病大鼠非酒精性脂肪性肝病, objectType=article, longId=301471, objectId=60643014e1be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60643014e1be, replyNumber=0, likeNumber=123, createdTime=2022-09-17, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60643014e1be, moduleTitle=Biomed Pharmacother：中药复方菩人丹可减轻老年2型糖尿病大鼠非酒精性脂肪性肝病, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=60643014e1be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810222, encodeId=e46a181022284, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=AP&T:司美鲁肽可以降低非酒精性脂肪性肝病的肝脏脂肪变性，但没有减少肝脏硬化, objectType=article, longId=292155, objectId=5daa292155ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5daa292155ff, replyNumber=0, likeNumber=108, createdTime=2022-11-18, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5daa292155ff, moduleTitle=AP&T:司美鲁肽可以降低非酒精性脂肪性肝病的肝脏脂肪变性，但没有减少肝脏硬化, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=5daa292155ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810232, encodeId=252118102323d, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Lancet Diabetes Endocrinol：非酒精性脂肪性肝病和糖尿病相互作用的全球视野, objectType=article, longId=301907, objectId=791d30190ef7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=791d30190ef7, replyNumber=0, likeNumber=78, createdTime=2022-09-22, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=791d30190ef7, moduleTitle=Lancet Diabetes Endocrinol：非酒精性脂肪性肝病和糖尿病相互作用的全球视野, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=791d30190ef7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810216, encodeId=43db1810216c9, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Efruxifermin (EFX) 治疗非酒精性脂肪性肝炎 (NASH)，FDA授予其“快速通道资格”, objectType=article, longId=218971, objectId=bfc82189e193, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfc82189e193, replyNumber=0, likeNumber=84, createdTime=2022-09-14, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfc82189e193, moduleTitle=Efruxifermin (EFX) 治疗非酒精性脂肪性肝炎 (NASH)，FDA授予其“快速通道资格”, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=bfc82189e193)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810208, encodeId=a41c181020888, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=代谢相关脂肪性肝病的饮食策略 , objectType=article, longId=215493, objectId=472c215493f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=472c215493f9, replyNumber=0, likeNumber=101, createdTime=2021-09-11, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=472c215493f9, moduleTitle=代谢相关脂肪性肝病的饮食策略 , moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=472c215493f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810233, encodeId=87551810233d2, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=JCEM：血清25-羟基维生素D水平变化对非酒精性脂肪性肝病发生风险和缓解的关系, objectType=article, longId=724923, objectId=9f53e249238c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f53e249238c, replyNumber=0, likeNumber=109, createdTime=2022-05-02, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f53e249238c, moduleTitle=JCEM：血清25-羟基维生素D水平变化对非酒精性脂肪性肝病发生风险和缓解的关系, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=9f53e249238c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810214, encodeId=06af1810214ec, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Nat Med：Aramchol治疗非酒精性脂肪性肝炎的疗效分析, objectType=article, longId=218294, objectId=f2f42182948a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2f42182948a, replyNumber=0, likeNumber=93, createdTime=2021-12-14, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2f42182948a, moduleTitle=Nat Med：Aramchol治疗非酒精性脂肪性肝炎的疗效分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f2f42182948a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

脂肪性

2020-05-29

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Hepatology | 非酒精性脂肪性肝炎的潜在治疗新靶点被发现

2023-03-19

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

European Radiology：在接受NAC的乳腺癌患者中，测量这一影像学指标可预测化疗相关脂肪性肝炎！

2022-08-21

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Radiology：超声衰减成像在非酒精性脂肪性肝炎诊断中的应用

2023-06-08

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

FDA授予辉瑞Ervogastat/Clesacostat用于非酒精性脂肪性肝炎 (NASH) 的快速通道资格

2022-11-01

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Neurology：非酒精性脂肪性肝病和纤维化与偶发痴呆和认知的相关性:鹿特丹研究

2023-03-26

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

非酒精性脂肪性肝炎的免疫细胞介导特征

2023-03-21

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Neurology：非酒精性脂肪性肝病:这种代谢状况有脑功能后遗症吗？

2022-08-19

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

APT：胰高糖素样肽-1受体激动剂在非酒精性脂肪性肝炎、肥胖和糖尿病中的作用！

2022-10-29

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

APT：胰高糖素样肽-1受体激动剂在非酒精性脂肪性肝炎、肥胖和糖尿病中的作用

2022-04-27

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Eur Heart J：复方丸预防心血管疾病，重点是非酒精性脂肪性肝炎

2022-05-26

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

JAMA Netw Open：成人2型糖尿病合并非酒精性脂肪性肝病严重低血糖分析

2022-08-04

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Front Immunol：银屑病与非酒精性脂肪性肝病之间的双向关联

2023-03-02

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

J Hepatol：口服FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的疗效

2021-11-23

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Biomed Pharmacother：中药复方菩人丹可减轻老年2型糖尿病大鼠非酒精性脂肪性肝病

2022-09-17

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

AP&T:司美鲁肽可以降低非酒精性脂肪性肝病的肝脏脂肪变性，但没有减少肝脏硬化

2022-11-18

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Lancet Diabetes Endocrinol：非酒精性脂肪性肝病和糖尿病相互作用的全球视野

2022-09-22

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Efruxifermin (EFX) 治疗非酒精性脂肪性肝炎 (NASH)，FDA授予其“快速通道资格”

2022-09-14

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

代谢相关脂肪性肝病的饮食策略

2021-09-11

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

JCEM：血清25-羟基维生素D水平变化对非酒精性脂肪性肝病发生风险和缓解的关系

2022-05-02

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Nat Med：Aramchol治疗非酒精性脂肪性肝炎的疗效分析

2021-12-14

科室
- - 订阅+
  - 更多科室
工具
服务